| Type | Title | Date Released | |
|---|---|---|---|
8-K | SINTX Reports Record Q3 2026 Revenue Growth and Advances Medical Device Commercialization | ||
10-Q | Form 10-Q | ||
DEF 14A | Form DEF 14A | ||
8-K | SINTX Technologies Announces Results of Class B Warrant Call, Raising Over $2 Million in Gross Proceeds | ||
8-K | SINTX Announces Preliminary $2.2 Million in Q3 Revenue, Exceeding High-End Guidance | ||
EFFECT | Form EFFECT | ||
SCHEDULE 13G | Bleichroeder LP (Filed by) | ||
8-K | SINTX Technologies Regains Compliance with Nasdaq Stockholders’ Equity Requirement | ||
S-3 | SHARE RESALE REGISTRATION | ||
8-K | SINTX Technologies Provides Mid-Year 2026 Business Update | ||
10-Q | Form 10-Q | ||
8-K | SINTX Technologies Engages Southern Metrics to Launch Strategic Opportunity Management Program |